The NEPTUNE Study for Angelman Syndrome
NEPTUNE is a pediatric clinical study evaluating the investigational
medicine gaboxadol (OV101), and it’s effect on individuals living with Angelman syndrome, such as the ability to sleep, use of gross and fine motor skills, behavior and communication.
The prescreener is no longer accepting new referrals at this time.
